Market Research Future adds new report of “Global Anti-Hypertensive Drugs Market Research Report- Forecast to 2022” it contains Company information, geographical data and Table of Content
Market Segments:
Global anti-hypertensive drugs market has been segmented on the basis of pharmacological class, hypertension type, disease source and Region.
According to a recent study report published by the Market Research Future, The global market of Anti-Hypertensive Drugs was valued at $32.2 billion in 2015, and is projected to reach $ USD 41.2 billion by 2023. Thus the market is anticipated to observe a sluggish growth; at a CAGR of 2.73% during 2016 to 2022.
Competitive Analysis
Key players in the antihypertensive drugs market are Sanofi S.A. (France), Novartis AG (Switzerland), AstraZeneca (U.K.), ... Read more
The Business Research Company’s Anti-Hypertensive Drugs Global Market Report 2019 covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market.
The anti-hypertensive drugs market consists of sales of anti-hypertensive drugs and related services. These drugs are re used ... Read more
TheBusinessResearchCompany published its Cardiovascular Drugs Global Market Report 2019 which provides strategists, marketers and senior management with the critical information they need to assess the global cardiovascular drugs market. The report covers the cardiovascular drugs market’s segments- anti-hypertensive drugs, hypolipidemics, anti thrombotics, other drugs for cardiovascular diseases (congestive heart failure, anti-arrhythmic and anti-anginal drugs).
This study covers the market dynamics and trends in major countries that are expected to influence the current market scenario and future status of the Global Anti-Hypertensive Drugs Market over the forecast period.
Novartis AG, Daiichi Sankyo Company Limited, Acetelion Ltd, Boehringer Ingelheim, Sanofi S.A., Astra Zeneca plc, Ranbaxy Laboratories Limited, Inc., Takeda Pharmaceuticals Company Limited, Pfizer Inc. are some of the prominent players at the forefront of competition in ... Read more
The Business Research Company published its Anti-Hypertensive Drugs Global Market Report 2019 which provides strategists, marketers and senior management with the critical information they need to assess the global anti-hypertensive drugs market. The report covers the anti-hypertensive drugs market’s segments- diuretics, angiotensin receptor blockers (ARBs), angiotensin converting enzyme (ACE) inhibitors, beta blockers, alpha blockers, calcium channel blockers, renin inhibitors, vasodilators ... Read more
Antihypertensive Drugs Market Research Report: by Therapeutic Class (Calcium Channel Blockers, Beta-adrenergic Blockers, Renin Inhibitors, ACE Inhibitors, Vasodilators, Diuretics, ARBs, Others), by Type (Primary Hypertension, Secondary Hypertension), by Distribution Channel (Retail Pharmacy, Hospital Pharmacy, E-commerce Websites & Online Drug Stores, Others), and Region - Global Forecast till 2023
According to a recent study report published by the Market Research Future, The ... Read more
According to a recent study report published by the Market Research Future, The global market of Anti-Hypertensive Drugs was valued at $32.2 billion in 2015, and is projected to reach $ USD 41.2 billion by 2023. Thus the anti-hypertensive drugs market is anticipated to observe a sluggish growth; at a CAGR of 2.73% during 2016 to 2022.
Anti-Hypertensive Drugs are used to treat hypertension (high blood pressure). Hypertension is a state of chronic elevated arterial blood pressure at ... Read more